bromodeoxyuridine has been researched along with Multiple Myeloma in 30 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 12 (40.00) | 18.7374 |
1990's | 9 (30.00) | 18.2507 |
2000's | 8 (26.67) | 29.6817 |
2010's | 1 (3.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Boireau, S; Bouhya, S; Cartron, G; Ceballos, P; Hose, D; Klein, B; Moreaux, J; Requirand, G; Robert, N; Seckinger, A; Vincent, L | 1 |
Cao, M; Chu, L; Dou, J; Gu, N; Hu, W; Jiang, C; Li, Y; Tang, Q; Wang, Y; Wen, P; Zhao, F | 1 |
Eto, M; Fujii, T; Hatayama, T; Hyodoh, F; Otsuki, T; Sakaguchi, H; Sugihara, T; Takata, A; Tsujioka, T | 1 |
Barlogie, B; Cottler-Fox, M; Epstein, J; Henderson, A; Wezeman, MJ; Yaccoby, S; Yi, Q | 1 |
Bataille, R; Pellat-Deceunynck, C; Robillard, N | 1 |
Yaccoby, S | 1 |
Andersen, TL; Boissy, P; Delaissé, JM; Haaber, J; Kupisiewicz, K; Kølvraa, S; Plesner, T; Rasmussen, T; Sondergaard, TE | 1 |
Alexanian, R; Barlogie, B; Drewinko, B; Latreille, J; Maddox, AM; Raber, MN; Smallwood, L; Swartzendruber, DE | 1 |
Adolf, GR; Fischer, P; Haas, OA; Swetly, P | 1 |
Borgström, GH; de la Chapelle, A; Elonen, E; Knuutila, S; Kovanen, R; Siimes, M; Vuopio, P | 1 |
Fattori, P; Gianni, L; Pasquini, E; Pini, E; Ravaioli, A; Sartori, S; Tassinari, D | 1 |
Bartl, R; Fateh-Moghadam, A; Lamerz, R; Schambeck, CM; Wick, M | 1 |
Battaglio, S; Boccadoro, M; Bruno, B; Napoli, P; Omedè, P; Palumbo, A; Pileri, A | 1 |
Battaglio, S; Boccadoro, M; Bruno, B; Fusaro, A; Napoli, P; Omedè, P; Palumbo, A; Pileri, A | 1 |
Bacovský, J; Budíková, M; Kubalová, D; Ordeltová, M; Scudla, V; Spidlová, A; Zivná, J | 1 |
Bacovský, J; Ordeltová, M; Scudla, V; Sedlár, D; Spidlová, A; Vavrdová, V | 1 |
Brown, R; Gibson, J; Joshua, D; Pope, B | 1 |
Barlogie, B; Brynes, RK; Butch, AW; Kelly, K; Lai, R; McCourty, A; Medeiros, LJ; Sawyer, JR; Wilson, CS | 1 |
Brynes, RK; Butch, AW; Kelly, K; Lai, R; McCourty, A; Medeiros, LJ; Wilson, CS | 1 |
Bojko, CH; Brent, JA; Hollander, VP | 1 |
Eberly, K; Gavin, JJ | 1 |
Cuomo, A; Girino, M; Luoni, R; Riccardi, A; Ucci, G | 1 |
Mantsygin, IuA; Morenkov, OS | 1 |
Barlogie, B; Kute, TE; McGuire, Wl; Meyer, JS | 1 |
Johnson, DA; Keating, MJ; Maddox, AM | 1 |
Cavo, M; Dinota, A; Gobbi, M; Lemoli, RM; Tura, S; Visani, G | 1 |
Canino, S; Ciani, C; Fagioli, M; Falini, B; Gerdes, J; Gobbi, M; Martelli, MF; Pileri, S; Sacchi, S; Stein, H | 1 |
Ballieux, RE; Bast, BJ; Boom, SE; Lokhorst, HM | 1 |
Boccadoro, M; Gavarotti, P; Pileri, A; Redoglio, V | 1 |
Mohit, B | 1 |
1 review(s) available for bromodeoxyuridine and Multiple Myeloma
Article | Year |
---|---|
Quantitative cytology in myeloma research.
Topics: Antigens; Bromodeoxyuridine; Cell Nucleolus; Cytoplasm; DNA; Flow Cytometry; Humans; Immunoglobulins; Multiple Myeloma; Proteins; RNA | 1982 |
1 trial(s) available for bromodeoxyuridine and Multiple Myeloma
Article | Year |
---|---|
Plasma cell proliferation in monoclonal gammopathies: measurement using BU-1 antibody in flow cytometry and microscopy: comparison with serum thymidine kinase.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal; Biomarkers; Bromodeoxyuridine; Cell Division; Controlled Clinical Trials as Topic; Female; Flow Cytometry; Humans; Male; Middle Aged; Mitotic Index; Multiple Myeloma; Paraproteinemias; Plasma Cells; Sensitivity and Specificity; Thymidine Kinase | 1995 |
28 other study(ies) available for bromodeoxyuridine and Multiple Myeloma
Article | Year |
---|---|
BrdU incorporation in multiparameter flow cytometry: A new cell cycle assessment approach in multiple myeloma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bromodeoxyuridine; Cell Cycle; Cell Proliferation; Cohort Studies; Diagnosis, Differential; Female; Flow Cytometry; Hematopoietic Stem Cell Transplantation; Humans; Indoles; Ki-67 Antigen; Lymphocyte Count; Male; Monoclonal Gammopathy of Undetermined Significance; Multiple Myeloma; Neoplasm, Residual; Plasma Cells; Prognosis; Progression-Free Survival; Recurrence; Staining and Labeling; Transplantation, Autologous | 2019 |
Identification of tumor stem-like cells in a mouse myeloma cell line.
Topics: Animals; Bromodeoxyuridine; Cell Line, Tumor; Cell Proliferation; Culture Media; Culture Media, Serum-Free; Flow Cytometry; Mice; Mice, Inbred BALB C; Multiple Myeloma; Neoplasm Transplantation; Neoplastic Stem Cells; Time Factors; Tumor Burden; Tumor Stem Cell Assay | 2009 |
IL-6 is a key factor in growth inhibition of human myeloma cells induced by pravastatin, an HMG-CoA reductase inhibitor.
Topics: Bromodeoxyuridine; Cell Cycle; Cell Division; Cell Line, Tumor; Coloring Agents; DNA, Complementary; Dose-Response Relationship, Drug; Enzyme Inhibitors; Flow Cytometry; Humans; Hydroxymethylglutaryl CoA Reductases; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Interleukin-6; Multiple Myeloma; Pravastatin; Reverse Transcriptase Polymerase Chain Reaction; RNA; Water | 2003 |
Cancer and the microenvironment: myeloma-osteoclast interactions as a model.
Topics: Annexin A5; Bone Diseases; Bone Marrow Cells; Bromodeoxyuridine; Carrier Proteins; Cell Differentiation; Cell Division; Cell Movement; Cell Survival; Coculture Techniques; Culture Media, Conditioned; Humans; Interleukin-6; Membrane Glycoproteins; Models, Biological; Multiple Myeloma; NF-kappa B; Osteoclasts; Osteogenesis; Phagocytosis; RANK Ligand; Receptor Activator of Nuclear Factor-kappa B | 2004 |
Phenotypic characterization of the human myeloma cell growth fraction.
Topics: Antibodies, Monoclonal; Apoptosis; Bone Marrow Cells; Bromodeoxyuridine; CD11a Antigen; Cell Proliferation; Cell Separation; Coloring Agents; Flow Cytometry; Humans; Leukocyte Common Antigens; Leukocytes, Mononuclear; Multiple Myeloma; Palatine Tonsil; Phenotype; Plasma Cells; Proto-Oncogene Proteins c-bcl-2 | 2005 |
The phenotypic plasticity of myeloma plasma cells as expressed by dedifferentiation into an immature, resilient, and apoptosis-resistant phenotype.
Topics: Antigens, CD19; Antigens, CD34; Apoptosis; Bromodeoxyuridine; Cell Differentiation; Cell Survival; Coculture Techniques; Dexamethasone; Flow Cytometry; Gene Expression Regulation, Neoplastic; Hematopoietic Stem Cells; Humans; Interleukin-6; Leukocyte Common Antigens; Membrane Glycoproteins; Multiple Myeloma; Osteoclasts; Phenotype; Plasma Cells; Proteoglycans; Reverse Transcriptase Polymerase Chain Reaction; Syndecan-1; Syndecans; Time Factors; Up-Regulation | 2005 |
Osteoclast nuclei of myeloma patients show chromosome translocations specific for the myeloma cell clone: a new type of cancer-host partnership?
Topics: Acid Phosphatase; Aged; Biomarkers, Tumor; Bromodeoxyuridine; Cell Differentiation; Cell Nucleus; Clone Cells; Coculture Techniques; Female; Flow Cytometry; Humans; Hybrid Cells; Image Interpretation, Computer-Assisted; In Situ Hybridization, Fluorescence; In Situ Nick-End Labeling; Integrins; Interphase; Isoenzymes; Male; Microscopy, Fluorescence; Middle Aged; Multiple Myeloma; Osteoclasts; Receptors, Vitronectin; Syndecan-1; Tartrate-Resistant Acid Phosphatase; Translocation, Genetic | 2007 |
Spontaneous production of alpha- and beta-interferon in human lymphoblastoid and lymphoma cell lines.
Topics: Bromodeoxyuridine; Cell Line; Dexamethasone; Dimethyl Sulfoxide; Hematopoiesis; Humans; Interferons; Kinetics; Leukemia; Lymphocytes; Lymphoma; Multiple Myeloma; Tetradecanoylphorbol Acetate | 1982 |
Culture of bone marrow reveals more cells with chromosomal abnormalities than the direct method in patients with hematologic disorders.
Topics: Acute Disease; Adolescent; Adult; Aged; Anemia, Sideroblastic; Bone Marrow Cells; Bromodeoxyuridine; Cells, Cultured; Child; Child, Preschool; Chromosome Aberrations; Chromosome Disorders; Clone Cells; Female; Hematologic Diseases; Humans; Leukemia; Leukemia, Myeloid; Lymphoma; Male; Middle Aged; Mitosis; Multiple Myeloma; Polycythemia Vera; Preleukemia | 1981 |
[Role of bone marrow plasma cell kinetics in the differential diagnosis of monoclonal gammopathies].
Topics: Adult; Aged; Aged, 80 and over; Bone Marrow Cells; Bromodeoxyuridine; Diagnosis, Differential; Female; Humans; Kinetics; Male; Middle Aged; Multiple Myeloma; Paraproteinemias; Plasma Cells | 1995 |
Retinoic acid inhibits the growth of human myeloma cells in vitro.
Topics: Antibodies, Neoplasm; Bromodeoxyuridine; Cell Division; Dexamethasone; Dose-Response Relationship, Drug; Drug Interactions; Humans; Immunoglobulins; Interferon Type I; Interferon-gamma; Isotretinoin; Multiple Myeloma; Recombinant Proteins; Tretinoin; Tumor Cells, Cultured | 1995 |
Recombinant interferon-gamma inhibits the in vitro proliferation of human myeloma cells.
Topics: Bone Marrow; Bromodeoxyuridine; Cell Division; Dexamethasone; Humans; Immunoglobulins; Interferon Type I; Interferon-gamma; Interleukin-6; Multiple Myeloma; Myeloma Proteins; Recombinant Proteins; Tumor Cells, Cultured | 1994 |
[The bromodeoxyuridine index in multiple myeloma. I. Relation with selected laboratory indicators of the disease].
Topics: Adult; Aged; Aged, 80 and over; Bromodeoxyuridine; Female; Fluorescent Antibody Technique; Humans; Male; Middle Aged; Multiple Myeloma; Plasma Cells | 1996 |
[Determination of the bromodeoxyuridine index in multiple myeloma. II. Relation to level of advancement and disease activity].
Topics: Bromodeoxyuridine; Humans; Multiple Myeloma; Prognosis | 1996 |
The bone marrow plasma cell labeling index by flow cytometry.
Topics: ADP-ribosyl Cyclase; ADP-ribosyl Cyclase 1; Aneuploidy; Antigens, CD; Antigens, Differentiation; Biotin; Bone Marrow Examination; Bromodeoxyuridine; Flow Cytometry; Fluorescein-5-isothiocyanate; Humans; Immunoglobulin G; Membrane Glycoproteins; Multiple Myeloma; NAD+ Nucleosidase; Plasma Cells; Reproducibility of Results; Streptavidin | 1999 |
Cyclin D1 and E2F-1 immunoreactivity in bone marrow biopsy specimens of multiple myeloma: relationship to proliferative activity, cytogenetic abnormalities and DNA ploidy.
Topics: Adult; Aged; Bone Marrow Cells; Bromodeoxyuridine; Carrier Proteins; Cell Cycle Proteins; Cell Division; Chromosomes, Human, Pair 11; Chromosomes, Human, Pair 14; Cyclin D1; Cytogenetic Analysis; DNA-Binding Proteins; E2F Transcription Factors; E2F1 Transcription Factor; Female; Flow Cytometry; Gene Amplification; Humans; Immunohistochemistry; Male; Middle Aged; Multiple Myeloma; Retinoblastoma-Binding Protein 1; Transcription Factor DP1; Transcription Factors; Translocation, Genetic | 2001 |
DNA topoisomerase IIalpha in multiple myeloma: a marker of cell proliferation and not drug resistance.
Topics: Adult; Aged; Antigens, Neoplasm; Biomarkers; Bone Marrow Cells; Bromodeoxyuridine; Cell Division; DNA Topoisomerases, Type II; DNA-Binding Proteins; Drug Resistance, Neoplasm; Glutathione Transferase; Humans; Immunohistochemistry; Isoenzymes; Ki-67 Antigen; Middle Aged; Multiple Myeloma | 2001 |
Toxicity of 5-bromo-2'-deoxyuridine to malignant lymphoid cell lines.
Topics: Antineoplastic Agents; Bromodeoxyuridine; Cell Division; Cell Line; Leukemia, Lymphoid; Lymphocytes; Lymphoma; Multiple Myeloma; Neoplasms, Experimental; Thymidine | 1977 |
Propagation and characterization of a rat myeloma cell line producing immunoglobulin E in vitro.
Topics: Animals; Bromodeoxyuridine; Cell Division; Cell Line; Immunoglobulin E; Multiple Myeloma; Neoplasms, Experimental; Rats | 1979 |
Monoclonal antibody Ki-67 as a marker of proliferative activity in monoclonal gammopathies.
Topics: Biomarkers; Bone Marrow; Bone Marrow Cells; Bromodeoxyuridine; Cell Division; Humans; Ki-67 Antigen; Multiple Myeloma; Nuclear Proteins; Paraproteinemias; Plasma Cells | 1991 |
[The demonstration of proliferating cells by using monoclonal antibodies to 5-bromo-2'-deoxyuridine in the peroxidase-antiperoxidase method].
Topics: Animals; Antibodies, Monoclonal; Antibody Specificity; Bromodeoxyuridine; Cell Division; Cell Line; Cells, Cultured; Cytological Techniques; Fibroblasts; Horseradish Peroxidase; Hybridomas; Immunization; Immunoenzyme Techniques; Mice; Mice, Inbred BALB C; Multiple Myeloma; Tumor Cells, Cultured | 1990 |
Impact of flow cytometry on predicting recurrence and survival in breast cancer patients.
Topics: Analysis of Variance; Aneuploidy; Breast Neoplasms; Bromodeoxyuridine; Carcinoma, Small Cell; Cell Cycle; Cell Line; DNA; Female; Flow Cytometry; Humans; Interphase; Lung Neoplasms; Lymph Nodes; Multiple Myeloma; Neoplasm Recurrence, Local; Prognosis; Receptors, Estrogen; Receptors, Progesterone; RNA; Thymidine | 1985 |
5-bromodeoxyuridine (BUdR) quenching of acridine orange fluorescence distinguishes cycling and non-cycling normal and malignant bone marrow cells in vitro.
Topics: Acridine Orange; Bone Marrow; Bromodeoxyuridine; Cell Cycle; DNA, Neoplasm; Humans; In Vitro Techniques; Leukemia; Multiple Myeloma; RNA, Neoplasm; Spectrometry, Fluorescence | 1989 |
Improvement of human myeloma stem cell growth in a liquid culture system supplemented with phytohemagglutinin.
Topics: Bone Marrow Cells; Bromodeoxyuridine; Culture Media; Immunoenzyme Techniques; Multiple Myeloma; Neoplastic Stem Cells; Phytohemagglutinins; Tumor Cells, Cultured | 1988 |
Immunocytochemical evaluation of the percentage of proliferating cells in pathological bone marrow and peripheral blood samples with the Ki-67 and anti-bromo-deoxyuridine monoclonal antibodies.
Topics: Antibodies, Monoclonal; Bone Marrow; Bromodeoxyuridine; Cell Division; Humans; Immunohistochemistry; Leukemia, Lymphoid; Lymphoma; Multiple Myeloma | 1988 |
Determination of the plasma cell labelling index with bromodeoxyuridine in a double fluorescence technique.
Topics: Bone Marrow; Bromodeoxyuridine; Cell Cycle; DNA; Fluorescent Antibody Technique; Humans; In Vitro Techniques; Monoclonal Gammopathy of Undetermined Significance; Multiple Myeloma; Plasma Cells; Thymidine; Time Factors | 1986 |
Multiple myeloma plasma cell kinetics: rapid and reliable evaluation using 5-bromo-2-deoxyuridine (BrdUrd) DNA incorporation detected by an anti-BrdUrd monoclonal antibody.
Topics: Antibodies, Monoclonal; Autoradiography; Bromodeoxyuridine; Cell Division; Humans; Interphase; Kinetics; Multiple Myeloma; Plasma Cells | 1986 |
Immunoglobulin G and free kapa-chain synthesis in different clones of a hybrid cell line.
Topics: Animals; Antigens; Azaguanine; Bromodeoxyuridine; Cell Fusion; Cell Line; Clone Cells; Complement System Proteins; Culture Media; Histocompatibility; Hybrid Cells; Immune Sera; Immunodiffusion; Immunoelectrophoresis; Immunoglobulin G; Immunoglobulins; Karyotyping; Lymphoma; Mice; Multiple Myeloma; Rabbits; Species Specificity | 1971 |